{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T20:49:44Z","timestamp":1793911784956,"version":"4.8.0"},"reference-count":71,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2025,2,5]],"date-time":"2025-02-05T00:00:00Z","timestamp":1738713600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,2,5]],"date-time":"2025-02-05T00:00:00Z","timestamp":1738713600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/100000065","name":"U.S. Department of Health & Human Services | NIH | National Institute of Neurological Disorders and Stroke","doi-asserted-by":"publisher","award":["R01NS094533"],"award-info":[{"award-number":["R01NS094533"]}],"id":[{"id":"10.13039\/100000065","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000065","name":"U.S. Department of Health & Human Services | NIH | National Institute of Neurological Disorders and Stroke","doi-asserted-by":"publisher","award":["R01NS106108"],"award-info":[{"award-number":["R01NS106108"]}],"id":[{"id":"10.13039\/100000065","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000065","name":"U.S. Department of Health & Human Services | NIH | National Institute of Neurological Disorders and Stroke","doi-asserted-by":"publisher","award":["R01CA241501"],"award-info":[{"award-number":["R01CA241501"]}],"id":[{"id":"10.13039\/100000065","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"U.S. Department of Health & Human Services | NIH | National Cancer Institute","doi-asserted-by":"publisher","award":["R01CA241501"],"award-info":[{"award-number":["R01CA241501"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"U.S. Department of Health & Human Services | NIH | National Cancer Institute","doi-asserted-by":"publisher","award":["P50CA190991"],"award-info":[{"award-number":["P50CA190991"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000050","name":"U.S. Department of Health & Human Services | NIH | National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","award":["R01HL106108"],"award-info":[{"award-number":["R01HL106108"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000050","name":"U.S. Department of Health & Human Services | NIH | National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","award":["R01HL106108"],"award-info":[{"award-number":["R01HL106108"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100001794","name":"Pediatric Brain Tumor Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001794","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006058","name":"St. Baldrick's Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006058","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010612","name":"ChadTough Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100010612","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Cancer"],"DOI":"10.1038\/s43018-025-00905-6","type":"journal-article","created":{"date-parts":[[2025,2,5]],"date-time":"2025-02-05T05:03:34Z","timestamp":1738731814000},"page":"460-473","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":84,"title":["FLASH radiation reprograms lipid metabolism and macrophage immunity and sensitizes medulloblastoma to CAR-T cell therapy"],"prefix":"10.1038","volume":"6","author":[{"given":"Haiwei","family":"Ni","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9122-9550","authenticated-orcid":false,"given":"Zachary J.","family":"Reitman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Zou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Md Naushad","family":"Akhtar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ritama","family":"Paul","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Menggui","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3215-2466","authenticated-orcid":false,"given":"Duo","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hao","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruitao","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruiying","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gina","family":"Ngo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1998-0611","authenticated-orcid":false,"given":"Lin","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric S.","family":"Diffenderfer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S. Azar Oliaei","family":"Motlagh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michele M.","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andy J.","family":"Minn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jay F.","family":"Dorsey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8001-5960","authenticated-orcid":false,"given":"Jessica B.","family":"Foster","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James","family":"Metz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Constantinos","family":"Koumenis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2086-205X","authenticated-orcid":false,"given":"David G.","family":"Kirsch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9670-8385","authenticated-orcid":false,"given":"Yanqing","family":"Gong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6290-0595","authenticated-orcid":false,"given":"Yi","family":"Fan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,2,5]]},"reference":[{"key":"905_CR1","doi-asserted-by":"publisher","first-page":"714","DOI":"10.1038\/nrclinonc.2014.181","volume":"11","author":"AJ Gajjar","year":"2014","unstructured":"Gajjar, A. J. & Robinson, G. W. Medulloblastoma\u2014translating discoveries from the bench to the bedside. Nat. Rev. Clin. Oncol. 11, 714\u2013722 (2014).","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"905_CR2","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1038\/s41572-019-0063-6","volume":"5","author":"PA Northcott","year":"2019","unstructured":"Northcott, P. A. et al. Medulloblastoma. Nat. Rev. Dis. Primers 5, 11 (2019).","journal-title":"Nat. Rev. Dis. Primers"},{"key":"905_CR3","doi-asserted-by":"publisher","first-page":"462","DOI":"10.1038\/s41591-019-0349-y","volume":"25","author":"J Zhao","year":"2019","unstructured":"Zhao, J. et al. Immune and genomic correlates of response to anti-PD-1 immunotherapy in glioblastoma. Nat. Med. 25, 462\u2013469 (2019).","journal-title":"Nat. Med."},{"key":"905_CR4","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.aaa0984","volume":"9","author":"DM O\u2019Rourke","year":"2017","unstructured":"O\u2019Rourke, D. M. et al. A single dose of peripherally infused EGFRvIII-directed CAR-T cells mediates antigen loss and induces adaptive resistance in patients with recurrent glioblastoma. Sci. Transl. Med. 9, eaaa0984 (2017).","journal-title":"Sci. Transl. Med."},{"key":"905_CR5","doi-asserted-by":"publisher","first-page":"7624","DOI":"10.1073\/pnas.1817147116","volume":"116","author":"YJ Xie","year":"2019","unstructured":"Xie, Y. J. et al. Nanobody-based CAR-T cells that target the tumor microenvironment inhibit the growth of solid tumors in immunocompetent mice. Proc. Natl Acad. Sci. USA 116, 7624\u20137631 (2019).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"905_CR6","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1200\/EDBK_237987","volume":"39","author":"M Datta","year":"2019","unstructured":"Datta, M., Coussens, L. M., Nishikawa, H., Hodi, F. S. & Jain, R. K. Reprogramming the tumor microenvironment to improve immunotherapy: emerging strategies and combination therapies. Am. Soc. Clin. Oncol. Educ. Book 39, 165\u2013174 (2019).","journal-title":"Am. Soc. Clin. Oncol. Educ. Book"},{"key":"905_CR7","doi-asserted-by":"publisher","first-page":"305","DOI":"10.3171\/jns.1979.50.3.0305","volume":"50","author":"RA Morantz","year":"1979","unstructured":"Morantz, R. A., Wood, G. W., Foster, M., Clark, M. & Gollahon, K. Macrophages in experimental and human brain tumors. Part 2: studies of the macrophage content of human brain tumors. J. Neurosurg. 50, 305\u2013311 (1979).","journal-title":"J. Neurosurg."},{"key":"905_CR8","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1038\/nn.4185","volume":"19","author":"D Hambardzumyan","year":"2016","unstructured":"Hambardzumyan, D., Gutmann, D. H. & Kettenmann, H. The role of microglia and macrophages in glioma maintenance and progression. Nat. Neurosci. 19, 20\u201327 (2016).","journal-title":"Nat. Neurosci."},{"key":"905_CR9","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1038\/nrc1256","volume":"4","author":"JW Pollard","year":"2004","unstructured":"Pollard, J. W. Tumour-educated macrophages promote tumour progression and metastasis. Nat. Rev. Cancer 4, 71\u201378 (2004).","journal-title":"Nat. Rev. Cancer"},{"key":"905_CR10","doi-asserted-by":"publisher","first-page":"462","DOI":"10.1016\/j.ccell.2015.02.015","volume":"27","author":"B Ruffell","year":"2015","unstructured":"Ruffell, B. & Coussens, L. M. Macrophages and therapeutic resistance in cancer. Cancer Cell 27, 462\u2013472 (2015).","journal-title":"Cancer Cell"},{"key":"905_CR11","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1016\/j.it.2015.02.004","volume":"36","author":"R Ostuni","year":"2015","unstructured":"Ostuni, R., Kratochvill, F., Murray, P. J. & Natoli, G. Macrophages and cancer: from mechanisms to therapeutic implications. Trends Immunol. 36, 229\u2013239 (2015).","journal-title":"Trends Immunol."},{"key":"905_CR12","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1172\/JCI59643","volume":"122","author":"A Sica","year":"2012","unstructured":"Sica, A. & Mantovani, A. Macrophage plasticity and polarization: in vivo veritas. J. Clin. Invest. 122, 787\u2013795 (2012).","journal-title":"J. Clin. Invest."},{"key":"905_CR13","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1038\/nri3073","volume":"11","author":"PJ Murray","year":"2011","unstructured":"Murray, P. J. & Wynn, T. A. Protective and pathogenic functions of macrophage subsets. Nat. Rev. Immunol. 11, 723\u2013737 (2011).","journal-title":"Nat. Rev. Immunol."},{"key":"905_CR14","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1084\/jem.176.1.287","volume":"176","author":"M Stein","year":"1992","unstructured":"Stein, M., Keshav, S., Harris, N. & Gordon, S. Interleukin 4 potently enhances murine macrophage mannose receptor activity: a marker of alternative immunologic macrophage activation. J. Exp. Med. 176, 287\u2013292 (1992).","journal-title":"J. Exp. Med."},{"key":"905_CR15","doi-asserted-by":"publisher","first-page":"935","DOI":"10.1038\/nm1620","volume":"13","author":"MS Weber","year":"2007","unstructured":"Weber, M. S. et al. Type II monocytes modulate T cell-mediated central nervous system autoimmune disease. Nat. Med. 13, 935\u2013943 (2007).","journal-title":"Nat. Med."},{"key":"905_CR16","doi-asserted-by":"publisher","first-page":"891","DOI":"10.1016\/j.ijrobp.2020.08.023","volume":"108","author":"EB Golden","year":"2020","unstructured":"Golden, E. B., Marciscano, A. E. & Formenti, S. C. Radiation therapy and the in situ vaccination approach. Int. J. Radiat. Oncol. Biol. Phys. 108, 891\u2013898 (2020).","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"905_CR17","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1269\/jrr.40.253","volume":"40","author":"Y Ibuki","year":"1999","unstructured":"Ibuki, Y. & Goto, R. Contribution of inflammatory cytokine release to activation of resident peritoneal macrophages after in vivo low-dose \u03b3-irradiation. J. Radiat. Res. 40, 253\u2013262 (1999).","journal-title":"J. Radiat. Res."},{"key":"905_CR18","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1002\/ijc.1030","volume":"96","author":"Y Hosoi","year":"2001","unstructured":"Hosoi, Y. et al. Induction of interleukin-1\u03b2 and interleukin-6 mRNA by low doses of ionizing radiation in macrophages. Int. J. Cancer 96, 270\u2013276 (2001).","journal-title":"Int. J. Cancer"},{"key":"905_CR19","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1016\/j.ccr.2013.09.014","volume":"24","author":"F Klug","year":"2013","unstructured":"Klug, F. et al. Low-dose irradiation programs macrophage differentiation to an iNOS+\/M1 phenotype that orchestrates effective T cell immunotherapy. Cancer Cell 24, 589\u2013602 (2013).","journal-title":"Cancer Cell"},{"key":"905_CR20","doi-asserted-by":"publisher","first-page":"37","DOI":"10.2307\/3578637","volume":"136","author":"A O\u2019Brien-Ladner","year":"1993","unstructured":"O\u2019Brien-Ladner, A., Nelson, M. E., Kimler, B. F. & Wesselius, L. J. Release of interleukin-1 by human alveolar macrophages after in vitro irradiation. Radiat. Res. 136, 37\u201341 (1993).","journal-title":"Radiat. Res."},{"key":"905_CR21","doi-asserted-by":"publisher","first-page":"157","DOI":"10.3389\/fphys.2013.00157","volume":"4","author":"JS Russell","year":"2013","unstructured":"Russell, J. S. & Brown, J. M. The irradiated tumor microenvironment: role of tumor-associated macrophages in vascular recovery. Front. Physiol. 4, 157 (2013).","journal-title":"Front. Physiol."},{"key":"905_CR22","doi-asserted-by":"publisher","first-page":"5196","DOI":"10.1128\/MCB.00079-08","volume":"28","author":"J Shao","year":"2008","unstructured":"Shao, J., Welch, W. J., Diprospero, N. A. & Diamond, M. I. Phosphorylation of profilin by ROCK1 regulates polyglutamine aggregation. Mol. Cell. Biol. 28, 5196\u20135208 (2008).","journal-title":"Mol. Cell. Biol."},{"key":"905_CR23","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1016\/j.ijrobp.2007.01.041","volume":"68","author":"CS Tsai","year":"2007","unstructured":"Tsai, C. S. et al. Macrophages from irradiated tumors express higher levels of iNOS, arginase-I and COX-2, and promote tumor growth. Int. J. Radiat. Oncol. Biol. Phys. 68, 499\u2013507 (2007).","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"905_CR24","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1016\/j.clon.2019.04.001","volume":"31","author":"MC Vozenin","year":"2019","unstructured":"Vozenin, M. C., Hendry, J. H. & Limoli, C. L. Biological benefits of Ultra-high Dose Rate FLASH radiotherapy: sleeping beauty awoken. Clin. Oncol. (R. Coll. Radiol.) 31, 407\u2013415 (2019).","journal-title":"Clin. Oncol. (R. Coll. Radiol.)"},{"key":"905_CR25","doi-asserted-by":"publisher","first-page":"245ra293","DOI":"10.1126\/scitranslmed.3008973","volume":"6","author":"V Favaudon","year":"2014","unstructured":"Favaudon, V. et al. Ultrahigh dose-rate FLASH irradiation increases the differential response between normal and tumor tissue in mice. Sci. Transl. Med. 6, 245ra293 (2014).","journal-title":"Sci. Transl. Med."},{"key":"905_CR26","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1080\/09553002.2020.1704912","volume":"96","author":"RM de Kruijff","year":"2020","unstructured":"de Kruijff, R. M. FLASH radiotherapy: ultra-high dose rates to spare healthy tissue. Int. J. Radiat. Biol. 96, 419\u2013423 (2020).","journal-title":"Int. J. Radiat. Biol."},{"key":"905_CR27","doi-asserted-by":"publisher","first-page":"4808","DOI":"10.1158\/0008-5472.CAN-21-1500","volume":"81","author":"A Velalopoulou","year":"2021","unstructured":"Velalopoulou, A. et al. FLASH proton radiotherapy spares normal epithelial and mesenchymal tissues while preserving sarcoma response. Cancer Res. 81, 4808\u20134821 (2021).","journal-title":"Cancer Res."},{"key":"905_CR28","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1001\/jamaoncol.2022.5843","volume":"9","author":"AE Mascia","year":"2023","unstructured":"Mascia, A. E. et al. Proton FLASH radiotherapy for the treatment of symptomatic bone metastases: the FAST-01 nonrandomized trial. JAMA Oncol. 9, 62\u201369 (2023).","journal-title":"JAMA Oncol."},{"key":"905_CR29","doi-asserted-by":"publisher","first-page":"10943","DOI":"10.1073\/pnas.1901777116","volume":"116","author":"P Montay-Gruel","year":"2019","unstructured":"Montay-Gruel, P. et al. Long-term neurocognitive benefits of FLASH radiotherapy driven by reduced reactive oxygen species. Proc. Natl Acad. Sci. USA 116, 10943\u201310951 (2019).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"905_CR30","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.80721","volume":"12","author":"RE Menjivar","year":"2023","unstructured":"Menjivar, R. E. et al. Arginase 1 is a key driver of immune suppression in pancreatic cancer. eLife 12, e80721 (2023).","journal-title":"eLife"},{"key":"905_CR31","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-018-03050-0","volume":"9","author":"Q Wang","year":"2018","unstructured":"Wang, Q. et al. Vascular niche IL-6 induces alternative macrophage activation in glioblastoma through HIF-2\u03b1. Nat. Commun. 9, 559 (2018).","journal-title":"Nat. Commun."},{"key":"905_CR32","doi-asserted-by":"publisher","first-page":"924","DOI":"10.1038\/nsmb.1474","volume":"15","author":"T Itoh","year":"2008","unstructured":"Itoh, T. et al. Structural basis for the activation of PPAR\u03b3 by oxidized fatty acids. Nat. Struct. Mol. Biol. 15, 924\u2013931 (2008).","journal-title":"Nat. Struct. Mol. Biol."},{"key":"905_CR33","doi-asserted-by":"publisher","first-page":"668","DOI":"10.1172\/JCI116247","volume":"91","author":"P Reaven","year":"1993","unstructured":"Reaven, P. et al. Effects of oleate-rich and linoleate-rich diets on the susceptibility of low density lipoprotein to oxidative modification in mildly hypercholesterolemic subjects. J. Clin. Invest. 91, 668\u2013676 (1993).","journal-title":"J. Clin. Invest."},{"key":"905_CR34","doi-asserted-by":"publisher","first-page":"6051","DOI":"10.3390\/cancers14246051","volume":"14","author":"C Paret","year":"2022","unstructured":"Paret, C. et al. GD2 expression in medulloblastoma and neuroblastoma for personalized immunotherapy: a matter of subtype. Cancers (Basel) 14, 6051 (2022).","journal-title":"Cancers (Basel)"},{"key":"905_CR35","doi-asserted-by":"publisher","first-page":"1284","DOI":"10.1056\/NEJMoa2210859","volume":"388","author":"F Del Bufalo","year":"2023","unstructured":"Del Bufalo, F. et al. GD2-CART01 for relapsed or refractory high-risk neuroblastoma. N. Engl. J. Med. 388, 1284\u20131295 (2023).","journal-title":"N. Engl. J. Med."},{"key":"905_CR36","doi-asserted-by":"publisher","first-page":"972","DOI":"10.1158\/1078-0432.CCR-13-0709","volume":"20","author":"JH Sampson","year":"2014","unstructured":"Sampson, J. H. et al. EGFRvIII mCAR-modified T-cell therapy cures mice with established intracerebral glioma and generates host immunity against tumor-antigen loss. Clin. Cancer Res. 20, 972\u2013984 (2014).","journal-title":"Clin. Cancer Res."},{"key":"905_CR37","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1038\/s43018-020-00147-8","volume":"2","author":"W Ma","year":"2021","unstructured":"Ma, W. et al. Targeting PAK4 to reprogram vascular microenvironment and improve CAR-T immunotherapy for glioblastoma. Nat. Cancer 2, 83\u201397 (2021).","journal-title":"Nat. Cancer"},{"key":"905_CR38","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1038\/210212a0","volume":"210","author":"S Hornsey","year":"1966","unstructured":"Hornsey, S. & Alper, T. Unexpected dose-rate effect in the killing of mice by radiation. Nature 210, 212\u2013213 (1966).","journal-title":"Nature"},{"key":"905_CR39","doi-asserted-by":"publisher","first-page":"847","DOI":"10.1038\/215847a0","volume":"215","author":"CD Town","year":"1967","unstructured":"Town, C. D. Effect of high dose rates on survival of mammalian cells. Nature 215, 847\u2013848 (1967).","journal-title":"Nature"},{"key":"905_CR40","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-19917-0","volume":"11","author":"AJ Wisdom","year":"2020","unstructured":"Wisdom, A. J. et al. Single cell analysis reveals distinct immune landscapes in transplant and primary sarcomas that determine response or resistance to immunotherapy. Nat. Commun. 11, 6410 (2020).","journal-title":"Nat. Commun."},{"key":"905_CR41","doi-asserted-by":"publisher","DOI":"10.1016\/j.radonc.2023.109741","volume":"186","author":"S Shukla","year":"2023","unstructured":"Shukla, S. et al. Ultra-high dose-rate proton FLASH improves tumor control. Radiother. Oncol. 186, 109741 (2023).","journal-title":"Radiother. Oncol."},{"key":"905_CR42","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1158\/1078-0432.CCR-20-0894","volume":"27","author":"P Montay-Gruel","year":"2021","unstructured":"Montay-Gruel, P. et al. Hypofractionated FLASH-RT as an effective treatment against glioblastoma that reduces neurocognitive side effects in mice. Clin. Cancer Res. 27, 775\u2013784 (2021).","journal-title":"Clin. Cancer Res."},{"key":"905_CR43","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1002\/jlb.66.5.733","volume":"66","author":"M Ricote","year":"1999","unstructured":"Ricote, M., Huang, J. T., Welch, J. S. & Glass, C. K. The peroxisome proliferator-activated receptor (PPAR\u03b3) as a regulator of monocyte\/macrophage function. J. Leukoc. Biol. 66, 733\u2013739 (1999).","journal-title":"J. Leukoc. Biol."},{"key":"905_CR44","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1038\/nrc3214","volume":"12","author":"JM Peters","year":"2012","unstructured":"Peters, J. M., Shah, Y. M. & Gonzalez, F. J. The role of peroxisome proliferator-activated receptors in carcinogenesis and chemoprevention. Nat. Rev. Cancer 12, 181\u2013195 (2012).","journal-title":"Nat. Rev. Cancer"},{"key":"905_CR45","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1016\/S0092-8674(00)81574-3","volume":"93","author":"L Nagy","year":"1998","unstructured":"Nagy, L., Tontonoz, P., Alvarez, J. G., Chen, H. & Evans, R. M. Oxidized LDL regulates macrophage gene expression through ligand activation of PPAR\u03b3. Cell 93, 229\u2013240 (1998).","journal-title":"Cell"},{"key":"905_CR46","doi-asserted-by":"publisher","first-page":"546","DOI":"10.1161\/01.ATV.19.3.546","volume":"19","author":"N Marx","year":"1999","unstructured":"Marx, N., Bourcier, T., Sukhova, G. K., Libby, P. & Plutzky, J. PPAR\u03b3 activation in human endothelial cells increases plasminogen activator inhibitor type-1 expression: PPAR\u03b3 as a potential mediator in vascular disease. Arterioscler. Thromb. Vasc. Biol. 19, 546\u2013551 (1999).","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"905_CR47","first-page":"1105","volume":"87","author":"RL Schild","year":"2002","unstructured":"Schild, R. L. et al. The activity of PPAR\u03b3 in primary human trophoblasts is enhanced by oxidized lipids. J. Clin. Endocrinol. Metab. 87, 1105\u20131110 (2002).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"905_CR48","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.radonc.2019.03.028","volume":"139","author":"DR Spitz","year":"2019","unstructured":"Spitz, D. R. et al. An integrated physico-chemical approach for explaining the differential impact of FLASH versus conventional dose rate irradiation on cancer and normal tissue responses. Radiother. Oncol. 139, 23\u201327 (2019).","journal-title":"Radiother. Oncol."},{"key":"905_CR49","doi-asserted-by":"publisher","first-page":"324","DOI":"10.2307\/3573572","volume":"52","author":"ER Epp","year":"1972","unstructured":"Epp, E. R., Weiss, H., Djordjevic, B. & Santomasso, A. The radiosensitivity of cultured mammalian cells exposed to single high intensity pulses of electrons in various concentrations of oxygen. Radiat. Res. 52, 324\u2013332 (1972).","journal-title":"Radiat. Res."},{"key":"905_CR50","doi-asserted-by":"publisher","first-page":"522","DOI":"10.2307\/3574801","volume":"76","author":"CC Ling","year":"1978","unstructured":"Ling, C. C., Michaels, H. B., Epp, E. R. & Peterson, E. C. Oxygen diffusion into mammalian cells following ultrahigh dose rate irradiation and lifetime estimates of oxygen-sensitive species. Radiat. Res. 76, 522\u2013532 (1978).","journal-title":"Radiat. Res."},{"key":"905_CR51","doi-asserted-by":"publisher","DOI":"10.1259\/bjr.20190702","volume":"93","author":"G Adrian","year":"2020","unstructured":"Adrian, G. et al. The FLASH effect depends on oxygen concentration. Br. J. Radiol. 93, 20190702 (2020).","journal-title":"Br. J. Radiol."},{"key":"905_CR52","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/j.radonc.2019.02.009","volume":"139","author":"M Buonanno","year":"2019","unstructured":"Buonanno, M., Grilj, V. & Brenner, D. J. Biological effects in normal cells exposed to FLASH dose rate protons. Radiother. Oncol. 139, 51\u201355 (2019).","journal-title":"Radiother. Oncol."},{"key":"905_CR53","doi-asserted-by":"publisher","first-page":"1497","DOI":"10.1158\/1078-0432.CCR-19-1440","volume":"26","author":"C Fouillade","year":"2020","unstructured":"Fouillade, C. et al. FLASH irradiation spares lung progenitor cells and limits the incidence of radio-induced senescence. Clin. Cancer Res. 26, 1497\u20131506 (2020).","journal-title":"Clin. Cancer Res."},{"key":"905_CR54","doi-asserted-by":"publisher","first-page":"2545","DOI":"10.1158\/1078-0432.CCR-23-1880","volume":"30","author":"R Ciccone","year":"2024","unstructured":"Ciccone, R. et al. GD2-targeting CAR-T-cell therapy for patients with GD2+ medulloblastoma. Clin. Cancer Res. 30, 2545\u20132557 (2024).","journal-title":"Clin. Cancer Res."},{"key":"905_CR55","doi-asserted-by":"publisher","first-page":"934","DOI":"10.1038\/s41586-022-04489-4","volume":"603","author":"RG Majzner","year":"2022","unstructured":"Majzner, R. G. et al. GD2-CAR T cell therapy for H3K27M-mutated diffuse midline gliomas. Nature 603, 934\u2013941 (2022).","journal-title":"Nature"},{"key":"905_CR56","doi-asserted-by":"publisher","first-page":"791","DOI":"10.1016\/j.trecan.2023.07.007","volume":"9","author":"BC Thomas","year":"2023","unstructured":"Thomas, B. C. et al. CAR-T cell therapies for diffuse midline glioma. Trends Cancer 9, 791\u2013804 (2023).","journal-title":"Trends Cancer"},{"key":"905_CR57","doi-asserted-by":"publisher","first-page":"1440","DOI":"10.1016\/j.ijrobp.2020.11.012","volume":"109","author":"YE Kim","year":"2021","unstructured":"Kim, Y. E. et al. Effects of ultra-high doserate FLASH irradiation on the tumor microenvironment in Lewis lung carcinoma: role of myosin light chain. Int. J. Radiat. Oncol. Biol. Phys. 109, 1440\u20131453 (2021).","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"905_CR58","doi-asserted-by":"publisher","first-page":"927","DOI":"10.1093\/neuonc\/noac248","volume":"25","author":"BD Allen","year":"2023","unstructured":"Allen, B. D. et al. Elucidating the neurological mechanism of the FLASH effect in juvenile mice exposed to hypofractionated radiotherapy. Neuro Oncol. 25, 927\u2013939 (2023).","journal-title":"Neuro Oncol."},{"key":"905_CR59","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1016\/j.cmet.2023.01.010","volume":"35","author":"D Zhang","year":"2023","unstructured":"Zhang, D. et al. PHGDH-mediated endothelial metabolism drives glioblastoma resistance to chimeric antigen receptor T cell immunotherapy. Cell Metab. 35, 517\u2013534 (2023).","journal-title":"Cell Metab."},{"key":"905_CR60","doi-asserted-by":"publisher","DOI":"10.1016\/j.xpro.2024.102898","volume":"5","author":"D Zhang","year":"2024","unstructured":"Zhang, D. et al. Protocol to generate traceable CAR-T cells for syngeneic mouse cancer models. STAR Protoc. 5, 102898 (2024).","journal-title":"STAR Protoc."},{"key":"905_CR61","doi-asserted-by":"publisher","first-page":"4683","DOI":"10.1038\/sj.emboj.7601886","volume":"26","author":"Y Liu","year":"2007","unstructured":"Liu, Y. et al. Somatic cell type specific gene transfer reveals a tumor-promoting function for p21(Waf1\/Cip1). EMBO J. 26, 4683\u20134693 (2007).","journal-title":"EMBO J."},{"key":"905_CR62","doi-asserted-by":"publisher","first-page":"6174","DOI":"10.1158\/0008-5472.CAN-11-1031","volume":"71","author":"D Ciznadija","year":"2011","unstructured":"Ciznadija, D., Liu, Y., Pyonteck, S. M., Holland, E. C. & Koff, A. Cyclin D1 and cdk4 mediate development of neurologically destructive oligodendroglioma. Cancer Res. 71, 6174\u20136183 (2011).","journal-title":"Cancer Res."},{"key":"905_CR63","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1038\/ncb2954","volume":"16","author":"Y Fan","year":"2014","unstructured":"Fan, Y. et al. Profilin-1 phosphorylation directs angiocrine expression and glioblastoma progression through HIF-1\u03b1 accumulation. Nat. Cell Biol. 16, 445\u2013456 (2014).","journal-title":"Nat. Cell Biol."},{"key":"905_CR64","doi-asserted-by":"publisher","first-page":"1801","DOI":"10.1172\/JCI84876","volume":"126","author":"M Huang","year":"2016","unstructured":"Huang, M. et al. c-Met-mediated endothelial plasticity drives aberrant vascularization and chemoresistance in glioblastoma. J. Clin. Invest. 126, 1801\u20131814 (2016).","journal-title":"J. Clin. Invest."},{"key":"905_CR65","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1016\/j.ijrobp.2019.10.049","volume":"106","author":"ES Diffenderfer","year":"2020","unstructured":"Diffenderfer, E. S. et al. Design, implementation, and in vivo validation of a novel proton FLASH radiation therapy system. Int. J. Radiat. Oncol. Biol. Phys. 106, 440\u2013448 (2020).","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"905_CR66","unstructured":"International Atomic Energy Agency. Absorbed Dose Determination in External Beam Radiotherapy: An International Code of Practice for Dosimetry Based on Standards of Absorbed Dose to Water. Technical Reports Series no. 398 (IAEA, 2001)."},{"key":"905_CR67","doi-asserted-by":"publisher","first-page":"1202","DOI":"10.1016\/j.ijrobp.2023.04.018","volume":"116","author":"W Zou","year":"2023","unstructured":"Zou, W. et al. Framework for quality assurance of ultrahigh dose rate clinical trials investigating FLASH effects and current technology gaps. Int. J. Radiat. Oncol. Biol. Phys. 116, 1202\u20131217 (2023).","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"905_CR68","doi-asserted-by":"publisher","first-page":"3573","DOI":"10.1016\/j.cell.2021.04.048","volume":"184","author":"Y Hao","year":"2021","unstructured":"Hao, Y. et al. Integrated analysis of multimodal single-cell data. Cell 184, 3573\u20133587 (2021).","journal-title":"Cell"},{"key":"905_CR69","doi-asserted-by":"publisher","DOI":"10.1186\/s13059-019-1874-1","volume":"20","author":"C Hafemeister","year":"2019","unstructured":"Hafemeister, C. & Satija, R. Normalization and variance stabilization of single-cell RNA-seq data using regularized negative binomial regression. Genome Biol. 20, 296 (2019).","journal-title":"Genome Biol."},{"key":"905_CR70","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-23832-3","volume":"12","author":"F Yang","year":"2021","unstructured":"Yang, F. et al. Synergistic immunotherapy of glioblastoma by dual targeting of IL-6 and CD40. Nat. Commun. 12, 3424 (2021).","journal-title":"Nat. Commun."},{"key":"905_CR71","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.abq3558","volume":"15","author":"F Yang","year":"2023","unstructured":"Yang, F. et al. Small-molecule toosendanin reverses macrophage-mediated immunosuppression to overcome glioblastoma resistance to immunotherapy. Sci. Transl. Med. 15, eabq3558 (2023).","journal-title":"Sci. Transl. Med."}],"container-title":["Nature Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s43018-025-00905-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s43018-025-00905-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s43018-025-00905-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,30]],"date-time":"2025-03-30T12:27:07Z","timestamp":1743337627000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s43018-025-00905-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,5]]},"references-count":71,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2025,3]]}},"alternative-id":["905"],"URL":"https:\/\/doi.org\/10.1038\/s43018-025-00905-6","relation":{},"ISSN":["2662-1347"],"issn-type":[{"value":"2662-1347","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,2,5]]},"assertion":[{"value":"22 November 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 January 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 February 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"D.G.K. is a cofounder of and stockholder in XRAD Therapeutics, which is developing radiosensitizers. D.G.K. is a member of the scientific advisory board and owns stock in Lumicell, a company commercializing intraoperative imaging technology. None of these affiliations represent a conflict of interest with respect to the work of this manuscript. D.G.K. is a coinventor on a patent for a handheld imaging device and is a coinventor on a patent for radiosensitizers. None of these patents are relevant to this manuscript. XRAD Therapeutics, Merck, Bristol Myers Squibb and Varian Medical Systems have provided research support to D.G.K. but this did not support the research described in this manuscript. Z.J.R. is listed as an inventor for intellectual property related to genetic testing for brain tumors that is managed by Duke Office of Licensing and Ventures, which is not relevant to this manuscript. The other authors declase no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}